Safety and Pharmacokinetic Study of RRx-001 in Cancer Subjects
Status:
Completed
Trial end date:
2015-02-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the safety and pharmacokinetic profile of RRx-001
for injection in subjects with advanced solid tumors or lymphomas for which there are no
currently accepted curative therapies. This study will also conduct an exploratory evaluation
of objective tumor response using CT or MRI.